9-cis-13,14-Dihydro Retinoic Acid

IMPURITIES

Product Details

CAT No.# CS-O-14857
Category Impurities
CAS 176019-01-5
Molecular Weight 32.45
Molecular Formula C20H30O2
Purity: >98%
Synonyms: 13,14-Dihydroretinoic acid; (4E,6Z,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-4,6,8-trienoic acid; CS-T-53244; 9-cis-13,14-Dihydro 13-methylretinoic Acid
Application Notes: Impurity in commercial preparation of Retinoic Acid. 9-cis-13,14-Dihydroretinoic Acid, is a derivative of Retinal , corotenoid component of the visual pigments.
References: Raab, W.P., et al.: Arch. Dermatol. Res., 256, 247 (1976), Bard, D.R., Br. J. Cancer, 35, 110 (1977), Juhl, H.J., et al.: Mutat. Res., 58, 317 (1978), Ward, A., et al.: Drugs, 26, 9 (1983), Ball, et al.: Biochem. J., 42, 516 (1948), OBrien, D.F., et al.: Science, 218, 961 (1982),
COA / MSDS:    View COA    MSDS    Enquire
The balance used are calibrated with weights traceable to National Standards NIST for accuracy
PEOPLE ALSO SEARCHED FOR: 1. (6R,7S)-7-(2-chloroacetamido)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
2. propan-2-yl-5-hydroxy-2-methyl-2-4-(3-nitrophenyl)-6-oxo-1,4,5,5-tetraahydropyridine-3-carboxylate
3. ([13C6]Leu5)-Ghrelin (human) (H-7252.1000)
4. Benidipine D7
5. Lauroside D
6. Triazolam 13C D3
7. Icatibant impurity 1
8. BISPHENOL AF (RING-13C12)
9. 0.1% TFA in Water ULC-MS
10. Metamizole EP Impurity C HCl
11. Silodosin Metabolite D4
12. Brivaracetam Carboxylic acid metabolite [UCB 42145]
13. Terbuthylazine D5
14. tibolone (848)
15. (Z)-Dimethylvinphos
16. Silodosin Metabolite
17. 2-Phenoxymethanesulfonanilide
18. Nimesulide EP Impurity A
19. Acetone HPLC
20. Nandrolone Decanoate EP impurity F


SMILES:
CC(/C=C/C(C(C)(CCC1)C)=C1C)=C/C=C/C(C)CC(O)=O



This page contains information about 9-cis-13,14-Dihydro Retinoic Acid Cas 176019-01-5 and its Impurities.
"Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk."